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Abstract
Introduction
Racial disparities exist in the rates of diabetes compli-
cations in the United States and in the state of Missouri.
It is unclear to what degree such disparities involve dia-
betes-related preventive care. We sought evidence for
racial disparities in diabetes-related preventive care
between non-Hispanic blacks and whites in Missouri.
Methods
We analyzed data from the Missouri Behavioral Risk
Factor Surveillance System from 1994 through 2002. This
state-specific survey is conducted annually among a repre-
sentative sample of Missourians. We examined data from
842 Missourians who reported a diagnosis of type 1 or type
2 diabetes and who had consulted a health professional in
the 12 months before they were interviewed. We analyzed
reported receipt of glycosylated hemoglobin testing, foot
examinations, and dilated eye examinations in the year
before interview.
Results
Non-Hispanic blacks were significantly less likely than
whites to report having had glycosylated hemoglobin test-
ing (odds ratio [OR], 0.47; 95% confidence interval [CI],
0.22–0.99) but more likely to report having received foot
examinations (OR, 1.99; 95% CI, 1.21–2.39). There was no
difference between blacks and whites in the probability of
dilated eye examinations (OR, 1.49; 95% CI, 0.94–2.36).
Conclusion
Compared with whites, non-Hispanic blacks in Missouri
receive adequate screening for diabetic complications but
not for glycemic control. Further studies are needed to
investigate whether these disparities are linked to differ-
ences in the rate of diabetes complications in Missouri.
Introduction
In the last decade, concerted efforts have been made to
increase regular screening for diabetes complications to
improve health outcomes. The American Diabetes
Association recommends annual foot and dilated eye
examinations; measurement of glycosylated hemoglobin
(HbA1c), lipids, creatinine, cholesterol, and urine protein;
and biannual measurement of blood pressure (1). These
recommendations have led to considerable increases in the
use of these tests in the last decade (2-4) and associated
decreases in the rate of diabetes complications (2-6).
Because provision of these diabetes preventive examina-
tions is monitored by many large clinics (3,7,8), by the U.S.
Department of Veterans Affairs (9), and by population-
based surveys, including the Medicare Current Beneficiary
Survey (10), the National Health and Nutrition
Examination Survey (NHANES) (2), and the Behavioral
Risk Factor Surveillance System (BRFSS) (11), these
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measures make it possible to compare diabetes quality of
care across diverse populations and health care systems.
U.S. incidence rates for diabetes mellitus and complica-
tions from diabetes are higher for racial minority groups
than for whites (10,12-20). Racial disparities in routine
preventive diabetes care may contribute to these higher
rates (10,12,13,21-24). Non-Hispanic black adults with dia-
betes who receive health care from U.S. managed care
organizations are reportedly less likely than whites to
receive annual HbA1c or eye screening (13,21). Reports
from nationally representative U.S. population data are
less consistent: one study analyzing Medicare claims data
from more than 300,000 beneficiaries nationwide found
that black Medicare beneficiaries are about a third less
likely than whites to have HbA1c measured or to be
referred for eye examinations (22). In contrast, reports
analyzing data from Veterans Affairs facilities, the
NHANES, and the BRFSS have not found racial differ-
ences in HbA1c testing, eye care, insulin use, or blood pres-
sure treatment for individuals with diabetes (5,23,25).
These findings suggest that some U.S. populations may
experience racial disparities in diabetes care, whereas oth-
ers do not.
In some U.S. states, large racial disparities exist in the
rates of diabetes complications. From 1992 to 2002 in
Missouri, diabetes-related deaths among non-Hispanic
blacks occurred at twice the rate among whites, and emer-
gency department visits for diabetes-related complications
among blacks were about four times more frequent than
among whites (26). Given that diabetes preventive care
reduces diabetes-related complications and mortality, we
hypothesized that diabetes preventive care would be less
frequently received by non-Hispanic blacks than by whites
in Missouri. We used state-specific data collected from the
Missouri BRFSS from 1994 through 2002 to determine
whether preventive diabetes care in Missouri differed by
race and whether these differences changed over time.
Methods
Data source and study population 
The U.S. Centers for Disease Control and Prevention
(CDC) collects annual, state-specific data for the BRFSS in
all 50 states and the District of Columbia. The Missouri
BRFSS uses a disproportionate stratified sampling
methodology to select respondents from seven state health
regions including the city of St Louis. Data are collected
through telephone interviews among a sample of noninsti-
tutionalized adults (aged 18 years and older) living in
households with a telephone (27).
In this analysis, we included 842 Missourians who report-
ed having a medical diagnosis of diabetes mellitus and non-
Hispanic black or white race, who consulted a physician or
health professional for a routine checkup in the year before
being interviewed, and who answered questions about their
diabetes preventive care during that period. Interviews
were conducted in 1994, 1996, 1997, 2000, and 2002. We
compiled data for these survey years to determine whether
there was any trend in the frequency of reported examina-
tions. We excluded other racial or ethnic groups that com-
prised only 4% of the total BRFSS sample because the
small sample size precluded statistical analysis.
The BRFSS includes questions about preventive health
practices and risk behaviors that are linked to chronic dis-
eases, injuries, and preventable infectious diseases in the
adult, noninstitutionalized civilian population. The set of
questions varies somewhat among states in a given year
and from year to year in a given state. Our analysis
focused on a common set of questions about diabetes-
related preventive care services (outcomes) that were
reported in Missouri during the years we analyzed:
whether respondents reported that, in the 12 months
before being interviewed, a health professional had con-
ducted a “hemoglobin A1c” blood test, checked their feet for
any sores or irritations, or performed an eye examination
in which the pupils were dilated. To focus our analysis on
the quality of health care received by respondents with dia-
betes, we included only respondents who had been to a
health professional in the 12 months before being inter-
viewed. These data were gathered for the Missouri BRFSS
in each of the survey years included in this study. Missouri
BRFSS survey methods and wording of questions about
the diabetes preventive care outcomes we analyzed did not
change substantially during this period. For the years ana-
lyzed, the Missouri BRFSS included questions about cho-
lesterol and blood pressure screening in 1997 only, so these
questions were not included in our analysis.
Data analysis
The BRFSS data are weighted by CDC to correct for the
differences in probability of selection. The weighting takes
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number of telephones per household, and telephone cover-
age. In addition, poststratification weighting accounts for
nonresponse by age, race, and sex and is based on the most
recent census data in each U.S. state. This weighting
allows inferences about the state population to be made
from the sample (27). In all of our analyses, we adjusted
and applied these weights to account for the sampling
scheme in Missouri.
We conducted descriptive analyses initially using two-
way contingency tables. We used multivariate logistic
regression to estimate the association between race (non-
Hispanic blacks compared with whites) and preventive
care outcomes. We tested whether other respondent char-
acteristics individually or jointly confounded these associ-
ations using likelihood ratio tests in these models.
Characteristics were included in the final model for each
outcome as adjustment variables if they changed the crude
odds ratios (ORs) describing the effect of race on the pre-
ventive care outcome under consideration by more than
10%. We adjusted all models for income, employment, and
enrollment in either a public or private health insurance
plan. We also used likelihood ratio tests to assess interac-
tions between race and other respondent characteristics
(including the year respondents were interviewed). Item
nonresponse was minimal except for income, which was
not reported by 14% of respondents. We used linear regres-
sion to impute income when these data were missing. We
replaced missing income values with those estimated by a
multivariate linear regression model that estimated
income as a function of all other variables that we includ-
ed in the preventive care models. We then refit the final
preventive care models using this imputed income vari-
able. To determine the degree to which nonresponse by
non-Hispanic black respondents may have led to selection
bias in our analysis, we used a logistic regression model to
estimate the association between race and nonresponse for
each preventive care outcome that was asked by the
BRFSS in the years we examined. We adjusted those esti-
mates for sex, age, income, education, employment status,
health insurance coverage, marital status, body mass
index (BMI), and the year respondents were interviewed.
We assessed model calibration for all models with the
Hosmer-Lemeshow test (28). All data management and
analyses were done with SAS, version 8.02 (SAS Institute
Inc, Cary, NC). We used an α level of .05 to define signifi-
cance. The study was approved by the University of
Missouri Institutional Review Board.
Results
Non-Hispanic blacks represented 16% of the Missouri
population with diabetes who were sampled during the
years we examined (Table 1). These respondents were
younger, had slightly less income, and were less likely to
be married than white respondents. Sex, education, BMI,
health coverage, and employment did not differ by race.
Among the sample, 66% reported having had their feet
checked by a health professional in the past year, with pro-
portionally higher rates among non-Hispanic blacks (Table
2). Crude ORs indicated that blacks were more likely than
whites to have had their feet checked in the past year.
After adjustment for employment, enrollment in health
insurance, BMI, and income, this difference remained sig-
nificant (OR, 1.99; 95% confidence interval [CI],
1.21–2.39).
Sixty-seven percent of respondents reported having had
a dilated eye examination in the past year, with a higher
proportion reporting this outcome among blacks (72%)
than whites (68%) (Table 2). Although the crude OR indi-
cated that blacks were more likely to have had an eye
examination than whites, this difference was not statisti-
cally significant. After the model was adjusted for health
insurance coverage, income, age, and employment, the
increased OR for blacks receiving an eye examination
remained nonsignificant (OR, 1.49; 95% CI, 0.94–2.36).
Among the sample, 90% reported having had at least one
HbA1c test in the past year. Blacks were less likely to
report having received this test than whites in the crude
analysis (Table 2). After adjustment for health insurance
coverage, employment, and income, this difference
remained significant (OR, 0.47; 95% CI, 0.22–0.99).
There was no evidence that blacks were selectively
excluded from the models because of nonresponse (Table
3). After the model was adjusted for respondent character-
istics and the year of interview, non-Hispanic blacks were
more likely to respond to questions about foot examination,
whereas there was no difference in nonresponse between
whites and blacks for the eye examination and HbA1c
models.
There was no evidence of interaction between race and
any of the adjustment variables in the regression models.
There was also no evidence for increasing or decreasing
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trend by year for any of the diabetes preventive care out-
comes that we considered (data not shown). All statistical
models described revealed appropriate (i.e., nonsignificant)
calibration based on the Hosmer-Lemeshow test.
Discussion
This study suggests that there was substantial underuse
of a key test of diabetes control, HbA1c level, among non-
Hispanic black Missourians with diabetes from 1994 to
2002. Blacks reported adequate preventive care for at least
two potential diabetes complications, retinopathy and neu-
ropathy, at least as frequently as whites; foot examination
was reported more frequently by blacks, and eye care did
not differ by race. Our finding of a disparity in HbA1c test-
ing differs from a previous national BRFSS analysis,
which found that non-Hispanic blacks did not differ from
other groups in receipt of preventive services (5).
Our results cannot be explained by differences in access
to medical care between blacks and whites, because all
respondents had been examined by a physician in the last
year. We included in our analysis only respondents who
had consulted a health care professional, because the
BRFSS does not include questions about why respondents
thought they did or did not have access to health care pro-
fessionals. Although people with diabetes may not receive
diabetes preventive care — either because they do not have
access to a care provider or because the provider does not
deliver the care — an analysis exploring reasons why indi-
vidual respondents did not consult a health care profes-
sional was beyond the scope of this study.
Low-income patients and patients without health insur-
ance are less likely to be up-to-date on preventive services
of all types (29); however, all of our regression models
adjusted for employment, income, and enrollment in
health insurance. Other factors related to the health care
encounter may also have an influence; U.S. physicians are
under pressure to see more patients in less time (24), a sit-
uation that reduces time spent on diabetes preventive care
(30). In one survey study of physicians, they reported that
their biggest challenge to adequate treatment of diabetes
was not patients’ race; it was inadequate time and
resources (31).
Differences in patients’ and health care providers’ per-
ceptions about the importance of diabetes in the patient’s
life may strongly influence providers’ delivery of preven-
tive diabetes care and patients’ achievement of optimal
glycemic control (31,32). Physicians in one large U.S.
health maintenance organization stated that there seemed
little reason to order HbA1c tests for black patients
because these tests had been consistently high in the
recent past (i.e., reflecting poor glycemic control) (21).
Similar practices among Missouri physicians may have
contributed to our finding that blacks reported having had
fewer HbA1c tests than whites in that state. In contrast,
blacks may have reported that they had received foot and
eye examinations at least as frequently  as whites because
both providers and patients perceived correctly that dia-
betes foot and eye complications occur frequently among
blacks (and thus are important to detect early). The alter-
native explanation, that black respondents preferentially
remembered foot examinations better and HbA1c tests
worse than white respondents, seems less reasonable.
Black patients depend heavily on the medical system to
help them manage their diabetes as they grow older
because they realize that their risk of a grave complication
is high (33). Non-Hispanic black, Hispanic, and white
patients all attend ophthalmologic, podiatric, and weight
reduction clinics equally when referred by their primary
care physician (21). Although black diabetes patients make
fewer outpatient physician visits and use emergency serv-
ices more than whites (10), we are unaware of any pub-
lished evidence that suggests that they are indifferent
about receiving diabetes preventive care.
Given the relatively high baseline prevalence of the
outcomes examined in this study, the adjusted ORs we
report, although valid and sound measures of associa-
tion, may not approximate relative risk to the extent
that they would if the baseline prevalence of the out-
comes was low. Although other methods of presenting
findings are available (i.e., model-adjusted probabili-
ties), we chose to report model findings in the more com-
mon format of model-adjusted ORs.
This study has several limitations. First, results from
the BRFSS may not equally represent all black residents
in Missouri. The BRFSS does not collect data on people
without telephones. Although our adjusted BRFSS
weights accounted for this at the state level, blacks from
rural areas of Missouri, where telephones are less common
than in urban areas, may have been underrepresented
(27). On the other hand, our analysis may have overesti-
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not afford a telephone are also less likely to receive regular
diabetes preventive care (34). Second, the BRFSS elicits
responses about medical care from patients rather than
from health care providers. Self-reported data are subject
to recall bias. Differences in socioeconomic status or cul-
tural or language barriers may have differentially affected
reporting patterns for blacks compared with whites. Third,
because the data from respondents from other ethnic
groups were sparse, our analysis only compared non-
Hispanic blacks to whites; however, similar observations
have been made about the difference in quality of care
between Hispanics and non-Hispanics. In fact, Hispanics
have less frequent HbA1c testing than non-Hispanic
blacks (21). Fourth, numerous responses to the HbA1c
question were missing, making the confidence intervals for
that outcome quite wide. Fifth, nonresponse to diabetes
preventive care questions was high for the HbA1c test
model; however, we found no association between race and
nonresponse for that outcome. Sixth, to examine trends in
diabetes care over time, we limited the number of out-
comes that we analyzed to those that were repeatedly
included in the Missouri BRFSS during the years we stud-
ied. Although we cannot generalize these results to other
preventive care practices, these findings are consistent
with what others have found (10,12,13,17,21,35,36).
Finally, because the BRFSS only surveys noninstitutional-
ized people, our results cannot be generalized to people
who live in nursing homes, prisons, or other institutions.
We cannot conclude, based on our results, that dispari-
ties in HbA1c testing lead to differences in rates of dia-
betes-related complications and mortality in Missouri,
because the BRFSS does not collect information on the
occurrence of diabetes complications; however, the results
are suggestive. In Michigan, non-Hispanic blacks with dia-
betes in a health maintenance organization had higher
HbA1c values and poorer renal function than whites, and
blacks did not receive recommended levels of preventive
diabetes care (37). In another Missouri survey, black
youths with diabetes had substantially poorer glycemic
control than their white counterparts, although that study
did not investigate the association between glycemic con-
trol and the quality of medical care that respondents
received (38). Another recent survey of non-Hispanic
blacks in Missouri revealed that respondents did not feel
that they received the same quality of health care as
whites (26). Further studies should investigate the associ-
ation between racial disparities in diabetes preventive care
and the occurrence of complications from diabetes in mid-
western U.S. states.
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Tables
Table 1. Demographic Characteristics of Respondents With
Diabetes, Missouri Behavioral Risk Factor Surveillance
System, 1994–2002
No. in sample (% of state  101 (16) 741 (84) 842 NA
population, weightedb)
Mean age, y  57.0 61.2  61.1  .04
(SD) (16.2) (12.7) (13.3)
Annual household income, %
<$10,000 20 12 13 .07
$10,000-19,999 22 27 26
>$20,000 58 61 61
Marital status, %
Married 44 65 62 .003
Not married 56 35 38
Sex, %
Female 47 48 51 .45
Male 53 52 49
Education, %
Some high school 21 20 20 .56
High school graduate 31 40 39
Some college 30 23 24
College graduate 18 17 17
Body mass index, %
Normal (<25) 30 22 24 .23
Overweight (25.0-29.9) 45 43 43
Obese (>30) 25 35 33
Have insurance, %
Yes 87 93 92 .11
No 13 7 8
Currently employed, %
Yes 40 31 33 .20
No 60 69 67
NA indicates not applicable.
aP values determined by chi-square test.
bWeighted to U.S. census data for Missouri.
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Table 2. Likelihood of Non-Hispanic Blacks Having Received Diabetes Preventive Care Compared With Whites, by Type of
Care, Missouri Behavioral Risk Factor Surveillance System, 1994–2004a
Foot examination (675) 66 87 (78) 373 (66) 1.80 (1.12-2.90) 2.13 (1.26-3.72) 1.99 (1.21-2.39)
Dilated eye examination (739) 67 85 (72) 424 (68) 1.22 (0.79-1.89) 1.65 (1.02-2.69) 1.49 (0.94-2.36)
HbA1c test (530) 90 76 (87) 415 (94) 0.41 (0.20-0.85) 0.46 (0.22-0.99) 0.47 (0.22-0.99)
OR indicates odds ratio; CI, confidence interval; HbA1c, hemoglobin A1c.
aNumbers and percentages represent weighted observations. 
bFoot examination model adjusted for employment, health insurance coverage, income, and body mass index; eye examination model adjusted for employ-
ment, health insurance coverage, income, and age; HbA1c test model adjusted for employment, health insurance coverage, and income. 
cMissing values for reported income were estimated using a multivariate linear regression model.
Table 3. Association Between Race and Nonresponse to Questions About Diabetes Preventive Care Among Non-Hispanic
Black and White Respondents With Diabetes (N = 800), Missouri Behavioral Risk Factor Surveillance System, 1994–2004
Foot examination 76 (9) 8 (8) 68 (9) 0.40 (0.15-1.06) 0.22 (0.08-0.61)
Dilated eye examination 16 (2) 1 (1) 15 (2) 0.31 (0.04-2.42) 0.33 (0.03-3.6)
HbA1c test 262 (31) 38 (37) 224 (30) 0.77 (0.45-1.32) 0.82 (0.41-1.64)
OR indicates odds ratio; CI, confidence interval; HbA1c, hemoglobin A1c.
aModels were adjusted for sex, age, income, education, employment status, health insurance coverage, marital status, body mass index, and year respon-
dents were interviewed.
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Non-Hispanic Blacks Compared With Whites
Preventive Care Service Respondents  Non-Hispanic  White,  Crude OR  Adjustedb OR Adjustedb OR, 
(n in Final Model) Examined, % Black, No. (%) No. (%) (95% CI) (95% CI) Imputedc (95% CI)
Nonresponse for Non-Hispanic 
Blacks Compared With Whites
Missing
Responses Among Missing 
Preventive  Total Missing  Non-Hispanic Responses Among Crude OR Adjusteda OR
Care Service Responses, No. (%) Blacks, No. (%)  Whites, No. (%) (95% CI) (95% CI)